Compare DexCom, Inc. (DXCM) vs Gigacloud Technology Inc (GCT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Gigacloud Technology Inc — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while Gigacloud Technology Inc trades at $57.26 (market cap $2.02B). The key difference: DexCom, Inc. is far larger — about 15.8× Gigacloud Technology Inc's market cap, and Gigacloud Technology Inc is trading nearer its 52-week high, DexCom, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Gigacloud Technology Inc for 21 Days on average.
| DXCM | GCT | |
|---|---|---|
Market Cap | $31.86B | $2.02B |
Volume | 3,607,070 | 1,020,985 |
Sector | Health | Technology |
52-Week High | $92.34 | $57.26 |
52-Week Low | $54.84 | $25.46 |
Typical Hold Time | 62 Days | 21 Days |
Enterprise Value | $31.32B | $2.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth from $2.9B in 2022 to $4.66B in 2025. Profit margins have expanded significantly to 17.93%, while analyst sentiment remains overwhelmingly positive with 81% buy ratings. Recent news highlights the company's focus on Type 2 diabetes market expansion and leadership appointments.
DXCM presents a compelling growth story with expanding profitability and market opportunities, though elevated valuation multiples and technical bearish signals warrant caution. The consensus price target of $95.07 suggests 13% upside potential, but investors should monitor competitive pressures and reimbursement challenges in the CGM market.
GCT trades at $56.42, up 0.82% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with 10.65% net margins and consistent earnings beats, though the current price exceeds analyst consensus targets. Recent news highlights institutional interest and European expansion potential.
GCT offers growth potential through international expansion and strong execution but faces risks from insider selling and valuation concerns. The stock trades above most analyst targets, suggesting limited near-term upside despite solid fundamentals and positive technical indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →
